XOMA Corp (NASDAQ:XOMA)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - XOMA

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - XOMA

  • Market Cap$345.300m
  • SymbolNASDAQ:XOMA
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS98419J2069

Company Profile

XOMA Corp is a biotechnology company. It discovers and develops human and humanized monoclonal antibody-based therapeutics. Its proprietary product candidates are X358, X213, X129, and Gevokizumab. The business operations of the company function through the United States, Europe, and the Asia Pacific. XOMA's primary source of revenue is from license and collaboration arrangements, contract services, and royalties and the majority of the revenue is generated from the United States.XOMA Corp is a biotechnology company. It discovers and develops human and humanized monoclonal antibody-based therapeutics.

Latest XOMA news

Currently there for this company. Visit our news hub for other news .